---
title: "cabergoline - Hyperprolactinemia"
sidebar: mydoc_sidebar
permalink: cabergolinehyperprolactinemia.html
toc: false 
---

{% include image.html file="cabergolinehyperprolactinemia.png" alt="cabergolinehyperprolactinemia" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D000077465 | Cabergoline | Drug |
| UniProt:P14416 | D2 dopamine receptor | Protein |
| GO:0007195 | Adenylate cyclase-inhibiting dopamine receptor signaling pathway | BiologicalProcess |
| CHEBI:17489 | 3',5'-cyclic AMP | ChemicalSubstance |
| GO:0051209 | Release of sequestered calcium ion into cytosol | BiologicalProcess |
| GO:1902722 | Positive regulation of prolactin secretion | BiologicalProcess |
| MESH:D006966 | Hyperprolactinemia | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Cabergoline | INCREASES ACTIVITY OF | D2 Dopamine Receptor |
| D2 Dopamine Receptor | PARTICIPATES IN | Adenylate Cyclase-Inhibiting Dopamine Receptor Signaling Pathway |
| Adenylate Cyclase-Inhibiting Dopamine Receptor Signaling Pathway | DECREASES ABUNDANCE OF | 3',5'-Cyclic Amp |
| 3',5'-Cyclic Amp | POSITIVELY REGULATES | Release Of Sequestered Calcium Ion Into Cytosol |
| Release Of Sequestered Calcium Ion Into Cytosol | CONTRIBUTES TO | Positive Regulation Of Prolactin Secretion |
| Positive Regulation Of Prolactin Secretion | CAUSES | Hyperprolactinemia |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB00248#mechanism-of-action](https://go.drugbank.com/drugs/DB00248#mechanism-of-action){:target="_blank"}